Success for gene therapy: render unto Caesar that which is Caesar's
Two reports now take away some of the mystery as to why two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cell and allay fears for the safety of gene therapy.
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2004
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507871/ |